Displaying drugs 1 - 25 of 12626 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| AT1391 | Not Available |  | Investigated for use/treatment in diabetes mellitus type 1 and 2. | Not Available |
| TAFA-93 | Not Available |  | Investigated for use/treatment in transplant (rejection). | Not Available |
| RO6953958 | Not Annotated |  | Not Annotated | Not Annotated |
| MEM 1414 | Not Available |  | Investigated for use/treatment in alzheimer's disease, depression, memory loss, and neurologic disorders. | Not Available |
| R1295 | Not Available |  | Investigated for use/treatment in rheumatoid arthritis. | Not Available |
| Iron isomaltoside 1000 | Not Annotated |  | Iron isomaltoside 1000 is under investigation in Iron Deficiency Anaemia. Iron isomaltoside 1000 has been investigated for the treatment and basic science of Anemia, Gastric Cancer, Esophageal Cancer, Chronic Kidney... | Hematinics |
| Inobrodib | Not Annotated |  | Not Annotated | Not Annotated |
| PAS-004 | Not Annotated |  | PAS-004 is an allosteric MEK 1/2 inhibitor being developed by Pasithea Therapeutics. It is being investigated for the treatment of neurofibromatosis 1 and Noonan syndrome. | Not Annotated |
| Veglin | Not Available |  | Investigated for use/treatment in cancer/tumors (unspecified) and solid tumors. | Not Available |
| Bentoquatam | Not Available |  | Used to prevent or reduce the severity of allergic contact dermatitis due to urushiol, the allergenic resin of poison ivy, poison oak, and poison sumac. | Dermatologicals |
| Povidone K30 | Not Available |  | When in complex with iodine, indicated for inducing antisepsis for prevention of infection in minor cuts, scrapes, and burns. | Not Available |
| RLY-2608 | Not Annotated |  | Not Annotated | Not Annotated |
| BHV-5000 | Not Annotated |  | BHV-5000 is an orally bioavailable, low-trapping, potent N-methyl-D-aspartate (NMDA) receptor antagonist. The active metabolite of BHV-5000 is lanicemine. | Not Annotated |
| SC12267 | Not Available |  | Investigated for use/treatment in multiple sclerosis and rheumatoid arthritis. | Not Available |
| Tinlorafenib | Not Annotated |  | Tinlorafenib (PF-07284890) is a potent, selective, highly brain-penetrant, small-molecule inhibitor of BRAF V600 mutations. | Not Annotated |
| PYM50018 | Not Available |  | Investigated for use/treatment in amyotrophic lateral sclerosis (ALS). | Not Available |
| Policresulen | Not Annotated |  | Not Annotated | Phenol and Derivatives |
| MT1621 | Not Annotated |  | Not Annotated | Not Annotated |
| Cavrotolimod | Not Annotated |  | Not Annotated | Not Annotated |
| ANA971 | Not Available |  | Investigated for use/treatment in hepatitis (viral, C). | Not Available |
| GT 389-255 | Not Available |  | Investigated for use/treatment in obesity. | Not Available |
| PXL-770 free acid anhydrous | Not Annotated |  | Not Annotated | Naphthalenes / Pyridines |
| NODAGA-THERANOST Ga-68 | Not Annotated |  | Not Annotated | Not Annotated |
| Carbopol 974P | Not Available |  | A polymer used as a lacrimal substitute to treat symptoms associated with dry eyes. | Spermatocidal Agents |
| Sirna-027 | Not Available |  | Investigated for use/treatment in macular degeneration. | Not Available |
Displaying drugs 1 - 25 of 12626 in total